Literature DB >> 22442352

How the FDA forgot the evidence: the case of donepezil 23 mg.

Lisa M Schwartz1, Steven Woloshin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22442352     DOI: 10.1136/bmj.e1086

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  8 in total

1.  The Drug Facts Box: Improving the communication of prescription drug information.

Authors:  Lisa M Schwartz; Steven Woloshin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-13       Impact factor: 11.205

Review 2.  The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease.

Authors:  William James Deardorff; Eliahu Feen; George T Grossberg
Journal:  Drugs Aging       Date:  2015-07       Impact factor: 3.923

3.  Sex Differences in the Prevalent Use of Oral Formulations of Cholinesterase Inhibitors in Older Adults with Dementia.

Authors:  Lynn Zhu; Paula A Rochon; Andrea Gruneir; Wei Wu; Vasily Giannakeas; Peter C Austin; Nathan M Stall; Lisa McCarthy; Amanda Alberga; Nathan Herrmann; Sudeep S Gill; Susan E Bronskill
Journal:  Drugs Aging       Date:  2019-09       Impact factor: 3.923

4.  Approvals and Timing of New Formulations of Novel Drugs Approved by the US Food and Drug Administration Between 1995 and 2010 and Followed Through 2021.

Authors:  Ravi Gupta; Christopher J Morten; Angela Y Zhu; Reshma Ramachandran; Nilay D Shah; Joseph S Ross
Journal:  JAMA Health Forum       Date:  2022-05-20

5.  Bright Side of Lignin Depolymerization: Toward New Platform Chemicals.

Authors:  Zhuohua Sun; Bálint Fridrich; Alessandra de Santi; Saravanakumar Elangovan; Katalin Barta
Journal:  Chem Rev       Date:  2018-01-16       Impact factor: 60.622

6.  Exploring the feasibility of using real-world data from a large clinical data research network to simulate clinical trials of Alzheimer's disease.

Authors:  Zhaoyi Chen; Hansi Zhang; Yi Guo; Thomas J George; Mattia Prosperi; William R Hogan; Zhe He; Elizabeth A Shenkman; Fei Wang; Jiang Bian
Journal:  NPJ Digit Med       Date:  2021-05-14

7.  Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.

Authors:  Nathan Herrmann; Krista L Lanctôt; David B Hogan
Journal:  Alzheimers Res Ther       Date:  2013-07-08       Impact factor: 6.982

8.  The timing of drug funding announcements relative to elections: a case study involving dementia medications.

Authors:  Sudeep S Gill; Neeraj Gupta; Chaim M Bell; Paula A Rochon; Peter C Austin; Andreas Laupacis
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.